⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for immtac

Every month we try and update this database with for immtac cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous MelanomaNCT02535078
Malignant Melan...
Tebentafusp (IM...
durvalumab
tremelimumab
18 Years - Immunocore Ltd
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaNCT03070392
Uveal Melanoma
IMCgp100
Dacarbazine
Ipilimumab
Pembrolizumab
18 Years - 99 YearsImmunocore Ltd
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaNCT03070392
Uveal Melanoma
IMCgp100
Dacarbazine
Ipilimumab
Pembrolizumab
18 Years - 99 YearsImmunocore Ltd
A Cohort IND Expanded Access Program for Supporting Patient Access to TebentafuspNCT04960891
Uveal Melanoma
Tebentafusp
18 Years - Immunocore Ltd
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: